Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1
Y Yuan, Y Miao, C Zeng, J Liu, X Chen, L Qian… - …, 2020 - Wiley Online Library
Summary Type‐I interferons (IFN‐I) are used as common antiviral drugs for a range of viral
diseases in clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative …
diseases in clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative …
Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1.
Y Yuan, Y Miao, C Zeng, J Liu, X Chen, L Qian… - …, 2020 - search.ebscohost.com
Type‐I interferons (IFN‐I) are used as common antiviral drugs for a range of viral diseases in
clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative regulators of …
clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative regulators of …
Small-molecule inhibitors of ubiquitin-specific protease 7 enhance type-I interferon antiviral efficacy by destabilizing SOCS1.
Y Yuan, Y Miao, C Zeng, J Liu, X Chen, L Qian… - Immunology, 2019 - europepmc.org
Type-I interferons (IFN-I) are used as common antiviral drugs for a range of viral diseases in
clinic. However, the antiviral efficacy of IFN-I is largely restricted by negative regulators of …
clinic. However, the antiviral efficacy of IFN-I is largely restricted by negative regulators of …
[HTML][HTML] Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1
Y Yuan, Y Miao, C Zeng, J Liu, X Chen, L Qian… - …, 2020 - ncbi.nlm.nih.gov
Summary Type‐I interferons (IFN‐I) are used as common antiviral drugs for a range of viral
diseases in clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative …
diseases in clinic. However, the antiviral efficacy of IFN‐I is largely restricted by negative …
Small-molecule inhibitors of ubiquitin-specific protease 7 enhance type-I interferon antiviral efficacy by destabilizing SOCS1
Y Yuan, Y Miao, C Zeng, J Liu, X Chen… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Type-I interferons (IFN-I) are used as common antiviral drugs for a range of viral diseases in
clinic. However, the antiviral efficacy of IFN-I is largely restricted by negative regulators of …
clinic. However, the antiviral efficacy of IFN-I is largely restricted by negative regulators of …